HR 2450
Prescription Drug Transparency and Affordability Act
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 3:52 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Prescription Drug Transparency and Affordability Act aims to increase oversight of pharmacy benefit management (PBM) services. It requires group health plans and health insurance issuers to ensure PBMs don’t limit information disclosure and provide relevant data for reporting. The bill mandates detailed reports on drug pricing, rebates, and dispensing channels, with the goal of promoting transparency and affordability in prescription drug costs. It also establishes a process for participants and beneficiaries to request specific claim-level information.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.